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with application of the optimization technique when 
compared to the clinical treatment plans. Secondary 
optimization of the brainstem with the urgent sparing factor 
was able to increase further sparing to the brainstem by up 
to 9.8%, with a subtle effect on the sparing of the remaining 
of the structures. In addition, PTV coverage was maintained 
to the same degree as the delivered treatment. 
 
Conclusion: The geometric optimization method allows 
enhancement of the existing arc geometries, resulting in 
significant improvements in OAR sparing, without increase to 
required treatment planning or delivery time. 
 
Poster: Physics track: Treatment planning: applications  
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Purpose or Objective: As patients with craniopharyngiomas 
make good prognoses and as pediatric patients seem to be 
more sensitive to radiation than adults, irradiation of normal 
tissue should be minimized. Recent studies suggest that 
radiation-induced injuries to the hippocampus play important 
roles in compromising neurocognitive functioning for patients 
with brain tumors and it could be important to spare the 
hippocampus using modern planning methods for patients 
with craniopharyngiomas. In terms of radiation techniques, 
3D conformal external beam radiotherapy delivered using 
dynamic conformal arc therapy (DCAT) and volumetric-
modulated arc therapy (VMAT) are clinically employed to 
treat for patients with craniopharyngiomas. While the use of 
non-coplanar beams in VMAT of malignant intracranial tumors 
has recently been reported, no dosimetric comparison has yet 
been made between VMAT using non-coplanar arcs (ncVMAT) 
and VMAT employing only coplanar arcs (coVMAT) among 
patients with craniopharyngiomas. We performed a planning 
study comparing dose distributions to the planning target 
volume (PTV), hippocampus, and other organs at risk (OAR) 
of DCAT, coVMAT, and ncVMAT. 
 
Material and Methods: DCAT, coVMAT, and ncVMAT plans 
were created for 10 patients with craniopharyngiomas. The 
prescription dose was 52.2 Gy in 29 fractions, and 99% of 
each PTV was covered by 90% of the prescribed dose. The 
maximum dose was held below 107% of the prescribed dose. 
CoVMAT and ncVMAT plans were formulated to satisfy the 
following criteria: the doses to the hippocampus were 
minimized, and the doses to the OAR were similar to or lower 
than those of DCAT. 
 
Results: The mean equivalent doses in 2-Gy fractions to 40% 
of the volumes of the bilateral hippocampus 
[EQD2(40%hippos)] were 15.4/10.8/6.5 Gy for 
DCAT/coVMAT/ncVMAT, respectively. The EQD2(40%hippos) 
for ncVMAT were <7.3 Gy, which is the threshold predicting 
cognitive impairment, as defined by Gondi et al.. The mean 
doses to normal brain tissue and the conformity indices were 
similar for the three plans, and the homogeneity indices were 
significantly better for coVMAT and ncVMAT compared with 
DCAT. 
 
 
 
 
Conclusion: NcVMAT is more appropriate than DCAT and 
coVMAT for patients with craniopharyngiomas. NcVMAT 
significantly reduces radiation doses to the bilateral 
hippocampus (to 50% that of the DCAT) without increasing 
the doses to normal brain tissue and other OAR. 
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Purpose or Objective: Advances in delivery techniques like 
intensity modulated radiotherapy (IMRT) and volumetric 
modulated arc therapy (VMAT) facilitated increased 
treatment plan complexity, leading to the inclusion of more 
organs-at-risk (OARs) for sparing. Initial treatment planning 
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studies typically evaluate whether extra sparing affects 
boost/elective planning target volume (PTVB/PTVE) dose 
coverage or homogeneity, sparing of previously included 
OARs or dose conformity. However, once novel techniques 
are introduced in routine clinical practice, predicted changes 
are rarely retrospectively evaluated or confirmed. We 
therefore analyzed longitudinal changes in plan quality for 
head and neck cancer (HNC) patients treated at our 
department from 2005-2015 following the introduction of 
new technologies and planning techniques. 
 
Material and Methods: 4x30 plans of oropharynx patients 
were selected from 4 distinct periods (P). P1: 7-field static 
IMRT plans with parotid gland sparing. P2: Dual arc VMAT 
plans including submandibular gland sparing. P3: VMAT with 
swallowing muscle sparing and further attempts to reduce 
parotid gland / oral cavity doses through manual interactivity 
during optimization. P4: VMAT with the same OARs as P3, but 
automatically optimized using in-house developed software. 
PTVE prescribed doses were 54.25-57.75Gy in P1/P2, and 
54.25Gy in P3/P4. 70Gy was prescribed to PTVB for all 
patients, delivered in 35 fractions as a simultaneous 
integrated boost. Plans were compared using mean dose to 
composite salivary glands (Dsal), swallowing muscles (Dswal) 
and oral cavity (Doc), PTVB/PTVE dose coverage (V95) and 
homogeneity indices (HI), and V5Gy (volume receiving 5Gy), 
V30Gy, V50Gy and mean dose to the body contour with PTV 
subtracted. 
 
Results: The Figure shows mean salivary gland, swallowing 
muscle and oral cavity DVHs for each period and the Table 
summarizes the mean dosimetric results. OAR sparing, 
swallowing muscle sparing in particular (P1=55.0Gy to 
P4=38.6Gy), gradually improved throughout the periods 
without compromising PTV dose coverage, homogeneity or 
conformity indexes. In addition, P3 improved Dsal/Doc over 
P2 by 6.3/7.5Gy, illustrative of gains facilitated by improved 
planner experience and planning technique used. 
Automatically optimized plans (P4) achieved similar OAR 
sparing, Body-PTV doses and PTV V95/HI values as P3 plans. 
Although depending on the degree of OAR-PTV overlap, 
individual OAR sparing could vary between the periods, such 
differences are inherent to this type of study. 
 
 
 
 
Conclusion: Successive improvements in radiotherapy 
technologies and planning techniques substantially improved 
HNC plan quality. Swallowing muscle sparing did not 
compromise sparing of other OARs, PTV dose coverage and 
homogeneity or dose deposition in the remainder of the 
body. On the contrary, salivary gland doses, HIB/HIE and 
Body-PTV doses generally decreased in P3/P4 compared to 
earlier periods.  
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Purpose or Objective: In this study, we aimed to compare 
the effect of 4D mid-ventilation vs. free breathing 3D CT 
technique on target volume differences and corresponding 
dosimetrical changes using intensity modulated radiation 
therapy (IMRT) for patients with locally advanced non small 
cell lung cancer (NSCLC). Furthermore, additional 
investigation was performed to evaluate the possible 
dosimetrical improvement by using volumetric modulated 
arctherapy (VMAT) instead of IMRT. 
 
Material and Methods: Twenty-three patients with locally 
advanced NSCLC were scanned with 4D-CT acquisition for 
treatment planning purpose. The different breathing phases 
were analyzed to obtain the tumor motion (direction and 
amplitude) and to determine which dataset better represents 
the mid-ventilation phase. Based on the gross tumor volume, 
two planning target volumes were generated for each 
patient: One using 15 mm margin in all three directions (PTV-
3D) and the other with 12 mm with the margin of 1/4 of the 
movement (= mid-ventilation approach, PTV-4D). For 
objective comparison, IMRT plans (3D-IMRT, 4D-IMRT) were 
made by using Pinnacle v9.0 (Philips, Eindhoven, the 
Netherlands) with identical optimization parameters. For the 
4D mid-vent, additional VMAT plan was generated. All DVH 
were collected using the VODCA package (Medical Software 
Solutions, Hagendorn, Switzerland). For the evaluation, the 
following dosimetric parameters were used: for 
corresponding PTV coverage using V95%, for lungs-PTV4D (for 
objective comparison of healthy lung volume) V20Gy and 
Dmean, for spinal cord Dmax, for oesophagus Dmean, while 
for heart V35Gy. All 4D plans were verified at the treatment 
machine following the institutions QA procedure. Differences 
were tested using the pairwise t-tests with the significance 
level of p<0.05. 
 
Results: Based on the 4D-CT analysis, the average (range) 
tumor motions were 3.1 (0-11.2) mm for cranio-caudal, 1.7 
(0-4.6) mm for antero-posterior and 1.9 (0-4.0) mm for 
lateral direction. The average PTV volumes were reduced on 
average with 14% (Table 1).  
